Amends the Anti-Drug Abuse Act of 1986 to prohibit any sale or offer for sale of drug paraphernalia.
Official title: A bill to amend section 1822 of the Anti-Drug Abuse Act of 1986 with respect to drug paraphernalia, and for other purposes.
This bill died when its Congress ended.
Bills don't carry over between Congresses. Without re-introduction in a new session, it cannot advance.
Amends the Anti-Drug Abuse Act of 1986 to prohibit any sale or offer for sale of drug paraphernalia. (Current law prohibits the offer for sale and transportation of drug paraphernalia in interstate or foreign commerce.) Directs the Attorney General to use the authority granted under the Controlled Substances Act to enforce the Anti-Drug Abuse Act of 1986 through the use of task forces consisting of appropriate Federal, State, and local personnel. Requires any person who commits the offense specified by this Act to forfeit to the United States (later to be transferred to the State in which the offense was committed) any profits, proceeds, interest, or property acquired or maintained in violation of this Act, and any interest in, security of, claim against, or property or contractual right affording a source of influence over any enterprise operated in violation of this Act, that the sentencing court determines, after a forfeiture hearing, was acquired or maintained as a result of narcotics racketeering or violating this Act.
Filed in the Senate
This senate bill has been filed and is working its way through Congress. It will need to pass both the Senate and the House, then be signed by the President to become law.
Who introduced this
Ask AI About This Bill
Get plain-language answers with direct quotes from the bill text.
Your Representatives
Enter your address to see how your representatives voted on this bill.
Your address is only used to find your district and is never saved. See how it works
Votes
Public Opinion
No votes yet — be the first to weigh in.
to cast your vote
Your voice matters — let representatives know where you stand.
Comments
No comments yet. to be the first to weigh in.